PTK2 and central nervous system cancer: zDHHC5 knockdown disrupted FAK S‐acylation and membrane distribution, impairing proliferation and invasion of glioma cancer cells, while a catalytically inactive zDHHC5 Cys134S mutant reduced glioma xenografts growth.